Paul Stuka Net Worth

The estimated Net Worth of Paul Stuka is at least $666 Thousand dollars as of 12 May 2023. Mr. Stuka owns over 175,000 units of InspireMD Inc stock worth over $666,071 and over the last 12 years he sold NSPR stock worth over $12. In addition, he makes $0 as Chairman of the Board at InspireMD Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Stuka NSPR stock SEC Form 4 insiders trading

Paul has made over 9 trades of the InspireMD Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 175,000 units of NSPR stock worth $285,250 on 12 May 2023.

The largest trade he's ever made was buying 250,000 units of InspireMD Inc stock on 16 April 2013 worth over $500,000. On average, Paul trades about 20,184 units every 119 days since 2013. As of 12 May 2023 he still owns at least 248,534 units of InspireMD Inc stock.

You can see the complete history of Mr. Stuka stock trades at the bottom of the page.

Paul Stuka biography

Paul S. Stuka is Chairman of the Board of the Company. He served as the managing member of Osiris Partners, LLC, an investment fund, since 2000. Prior to forming Osiris Partners, LLC, Mr. Stuka, with 35 years of experience in the investment industry, was a managing director of Longwood Partners, managing small cap institutional accounts. In 1995, Mr. Stuka joined State Street Research and Management as manager of its Market Neutral and Mid Cap Growth Funds. From 1986 to 1994, Mr. Stuka served as the general partner of Stuka Associates, where he managed a U.S.-based investment partnership. Mr. Stuka began his career in 1980 as an analyst at Fidelity Management and Research. As an analyst, Mr. Stuka followed a wide array of industries including healthcare, energy, transportation, and lodging and gaming. Early in his career he became the assistant portfolio manager for three Fidelity Funds, including the Select Healthcare Fund which was recognized as the top performing fund in the U.S. for the five-year period ending December 31, 1985. Mr. Stuka has served as a director of Caliber Imaging & Diagnostics, Inc. (formerly Lucid, Inc.) since June 2013. Mr. Stuka’s qualifications to serve on the board include his significant strategic and business insight from his years of experience investing in the healthcare industry.

How old is Paul Stuka?

Paul Stuka is 61, he's been the Chairman of the Board of InspireMD Inc since 2017. There are 3 older and 7 younger executives at InspireMD Inc. The oldest executive at InspireMD Inc is Dr. Sol J. Barer Ph.D., 74, who is the Special Advisor to the Board.

What's Paul Stuka's mailing address?

Paul's mailing address filed with the SEC is C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV, L3, 6744832.

Insiders trading at InspireMD Inc

Over the last 13 years, insiders at InspireMD Inc have traded over $1,684,082 worth of InspireMD Inc stock and bought 3,887,125 units worth $5,293,286 . The most active insiders traders include Sol J Barer, Eli Bar, and Gary S Roubin. On average, InspireMD Inc executives and independent directors trade stock every 97 days with the average trade being worth of $319,459. The most recent stock trade was executed by Gary S Roubin on 30 November 2023, trading 50,000 units of NSPR stock currently worth $126,500.

What does InspireMD Inc do?

inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.

Complete history of Mr. Stuka stock trades at InspireMD Inc

InspireMD Inc executives and stock owners

InspireMD Inc executives and other stock owners filed with the SEC include:

• Marvin L. Slosman,
  Pres, CEO & Director
• Craig Shore,
  CFO, Chief Admin. Officer, Sec. & Treasurer
• Craig Shore,
  Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary
• Campbell Rogers,
  Independent Director
• Michael Berman,
  Independent Director
• Gary Roubin,
  Director
• Thomas Kester,
  Director
• Agustin Gago,
  Executive Vice President, Chief Commercial Officer
• Isaac Blech,
  Independent Vice Chairman of the Board
• Marvin Slosman,
  Chief Executive Officer, Director
• Paul Stuka,
  Chairman of the Board
• Dr. Sol J. Barer Ph.D.,
  Special Advisor to the Board
• Amir Kohen,
  VP of Fin. & International HR
• Andrea Tommasoli,
  Sr. VP of Global Sales & Marketing
• Roei Samuri,
  VP of Operations
• Sol J Barer,
  Director
• James J Barry,
  President and CEO
• James J Loughlin,
  Director
• Alan Milinazzo,
  President and CEO
• Eric L. Olson,
  VP of Global Sales Operations
• Eli Bar,
  CTO InspireMD Ltd.
• Asher Holzer,
  Director
• Eyal Weinstein,
  Director
• Kathryn Arnold,
  Director
• Shane Thomas Gleason,
  Chief Commercial Officer
• Patrick Verta,
  EVP Clinical/Medical Affairs